DD vs EMBC · P/E 127, rev $12.39B vs P/E 12, rev $1.08B
Dupont De Nemours Inc (DD) versus Embecta Corp (EMBC) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
DD currently screens at market cap $19.61B and trailing P/E 127.4. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Not investment advice. Open the DD and EMBC stock pages for the full models.
Not investment advice.